RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.
Gold SJ, Hoang CV, Potts BW, Porras G, Pioli E, Kim KW, Nadjar A, Qin C, LaHoste GJ, Li Q, Bioulac BH, Waugh JL, Gurevich E, Neve RL, Bezard E.
Gold SJ, et al. Among authors: potts bw.
J Neurosci. 2007 Dec 26;27(52):14338-48. doi: 10.1523/JNEUROSCI.4223-07.2007.
J Neurosci. 2007.
PMID: 18160641
Free PMC article.